ImageneBio, Inc. - IMA

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Nov 13, 2026 SCHEDULE 13G/A Blue Owl Capital Holdings LP 9.11% 1,135,081 View
Aug 14, 2026 SCHEDULE 13G/A BIOTECHNOLOGY VALUE FUND L P 5.4% 611,834 View
Aug 14, 2026 SCHEDULE 13G/A BVF I GP LLC 5.4% 611,834 View
Aug 14, 2026 SCHEDULE 13G/A BIOTECHNOLOGY VALUE FUND II LP 3.8% 433,269 View
Aug 14, 2026 SCHEDULE 13G/A BVF II GP LLC 3.8% 433,269 View
Aug 14, 2026 SCHEDULE 13G/A Biotechnology Value Trading Fund OS LP 0.6% 66,808 View
Aug 14, 2026 SCHEDULE 13G/A BVF Partners OS Ltd. 0.6% 66,808 View
Aug 14, 2026 SCHEDULE 13G/A BVF GP HOLDINGS LLC 9.3% 1,045,103 View
Aug 14, 2026 SCHEDULE 13G/A BVF PARTNERS L P/IL 9.9% 1,128,647 View
Aug 14, 2026 SCHEDULE 13G/A BVF INC/IL 9.9% 1,128,647 View
Aug 14, 2026 SCHEDULE 13G/A LAMPERT MARK N 9.9% 1,128,647 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.